These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11425954)

  • 1. Long-term continuation of levetiracetam in patients with refractory epilepsy.
    Krakow K; Walker M; Otoul C; Sander JW
    Neurology; 2001 Jun; 56(12):1772-4. PubMed ID: 11425954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long term retention of levetiracetam in a large cohort of patients with epilepsy.
    Depondt C; Yuen AW; Bell GS; Mitchell T; Koepp MJ; Duncan JS; Sander JW
    J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):101-3. PubMed ID: 16361605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy.
    Ben-Menachem E; Edrich P; Van Vleymen B; Sander JW; Schmidt B
    Epilepsy Res; 2003 Feb; 53(1-2):57-64. PubMed ID: 12576168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy.
    Ben-Menachem E; Gilland E
    Seizure; 2003 Apr; 12(3):131-5. PubMed ID: 12651076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
    von Stuelpnagel C; Holthausen H; Kluger G
    Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention rate of levetiracetam in children with intractable epilepsy at 1 year.
    Peake D; Mordekar S; Gosalakkal J; Mukhtyar B; Buch S; Crane J; Wheway R; Rittey C; Donnelly J; Whitehouse WP; Philip S
    Seizure; 2007 Mar; 16(2):185-9. PubMed ID: 17258474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term levetiracetam treatment of epilepsy patients: clinical audit.
    Kuba R; Novotná I; Brázdil M; Kocvarová J; Tyrliková I; Mastík J; Rektor I
    Epilepsy Res; 2006 Dec; 72(2-3):111-9. PubMed ID: 16930945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of levetiracetam (keppra) add-on treatment in adult patients with refractory epilepsy in two tertiary centers].
    Auriel E; Chistik V; Blatt I; Margolin N; Neufeld M
    Harefuah; 2007 Apr; 146(4):269-71, 318. PubMed ID: 17476932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam monotherapy for elderly patients with epilepsy.
    Alsaadi TM; Koopmans S; Apperson M; Farias S
    Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with levetiracetam in childhood epilepsy].
    Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A
    Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up.
    Kuba R; Novotná I; Brázdil M; Kocvarová J; Tyrlíková I; Mastík J; Rektor I
    Acta Neurol Scand; 2010 Feb; 121(2):83-8. PubMed ID: 20003081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis.
    Hirsch M; Hintz M; Specht A; Schulze-Bonhage A
    Seizure; 2018 Oct; 61():98-103. PubMed ID: 30118932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical efficacy of the novel antiepileptic agent levetiracetam: evaluation in patients with localization-related epilepsy].
    Yamazoe T; Fujimoto A; Yamazaki M; Yokota T; Okanishi T; Uchiyama T; Ohashi T; Tanaka T; Enoki H; Yamamoto T
    Brain Nerve; 2012 Oct; 64(10):1169-74. PubMed ID: 23037607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
    Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
    Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness and safety of long-term levetiracetam treatment in patients with refractory epilepsy].
    Matsuo M; Fuji A; Matsuzaka T; Baba H; Toda K; Ono T; Tanaka S; Sato T; Moriuchi H
    No To Hattatsu; 2015 Jul; 47(4):272-8. PubMed ID: 26353448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam in pediatrics.
    Vigevano F
    J Child Neurol; 2005 Feb; 20(2):87-93. PubMed ID: 15794171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of adjunctive levetiracetam in children younger than 4 years with refractory epilepsy].
    Hu Y; Liao JX; Chen L; Huang TS; Li B
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Apr; 12(4):256-8. PubMed ID: 20416214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.